Metro Minnesota Community Clinical Oncology Program is a clinical research site located in Saint Louis Park, Minnesota, United States 55426.
Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.
Metro Minnesota Community Clinical Oncology Program has participated in 4 clinical trials.
Therapeutic areas: Peripheral T-cell Lymphoma, Diffuse Large B-cell Lymphoma, de Novo DLBCL.
Sponsors: Acrotech Biopharma Inc., CTI BioPharma, Momenta Pharmaceuticals, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Minnesota · View every site in Saint Louis Park
Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Metro Minnesota Community Clinical Oncology Program has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Metro Minnesota Community Clinical Oncology Program has 4 clinical trials on record. Their work covers Peripheral T-cell Lymphoma, Diffuse Large B-cell Lymphoma, de Novo DLBCL.
Metro Minnesota Community Clinical Oncology Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.